Ganglion Impar Neurolysis in the Management of Pelvic and Perineal Cancer-Related Pain.

Detalhes bibliográficos
Autor(a) principal: Ferreira, F
Data de Publicação: 2020
Outros Autores: Pedro, A
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.10/2461
Resumo: Cancer-related pain is a very prevalent problem in all stages, with 10% of patients requiring invasive techniques for adequate pain management. Ganglion impar neurolysis has been used in the treatment of pelvic-perineal pain with efficacy and rare complications, but only a few case or series reports in cancer patients have been published. We report the case of a patient presenting with an ovarian carcinoma (FIGO stage IIIC), who had several disease relapses at the colorectal transition and need for palliative colic prosthesis. She presented later with anorectal pain associated with a rectovaginal fistula, which had an important impact on the activities of her daily life. She was submitted to two ganglion impar neurolyses, which resulted in improved pain control for a total of 5 months, an important improvement in her quality of life, and reduction of opioid consumption. The authors aim to alert to the importance of pain control and to address the fourth step of the WHO analgesic ladder as an option for cancer patients, including palliative patients.
id RCAP_1299e28c2cbe6d842a04a2e3c42a208e
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/2461
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Ganglion Impar Neurolysis in the Management of Pelvic and Perineal Cancer-Related Pain.Pelvic painNeoplasmsPain managementMorphineCancer-related pain is a very prevalent problem in all stages, with 10% of patients requiring invasive techniques for adequate pain management. Ganglion impar neurolysis has been used in the treatment of pelvic-perineal pain with efficacy and rare complications, but only a few case or series reports in cancer patients have been published. We report the case of a patient presenting with an ovarian carcinoma (FIGO stage IIIC), who had several disease relapses at the colorectal transition and need for palliative colic prosthesis. She presented later with anorectal pain associated with a rectovaginal fistula, which had an important impact on the activities of her daily life. She was submitted to two ganglion impar neurolyses, which resulted in improved pain control for a total of 5 months, an important improvement in her quality of life, and reduction of opioid consumption. The authors aim to alert to the importance of pain control and to address the fourth step of the WHO analgesic ladder as an option for cancer patients, including palliative patients.KargerRepositório do Hospital Prof. Doutor Fernando FonsecaFerreira, FPedro, A2020-07-07T13:29:44Z2020-01-01T00:00:00Z2020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/2461engCase Rep Oncol. 2020 Jan 20;13(1):29-341662-657510.1159/000505181info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-20T15:53:07Zoai:repositorio.hff.min-saude.pt:10400.10/2461Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:53:22.325396Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Ganglion Impar Neurolysis in the Management of Pelvic and Perineal Cancer-Related Pain.
title Ganglion Impar Neurolysis in the Management of Pelvic and Perineal Cancer-Related Pain.
spellingShingle Ganglion Impar Neurolysis in the Management of Pelvic and Perineal Cancer-Related Pain.
Ferreira, F
Pelvic pain
Neoplasms
Pain management
Morphine
title_short Ganglion Impar Neurolysis in the Management of Pelvic and Perineal Cancer-Related Pain.
title_full Ganglion Impar Neurolysis in the Management of Pelvic and Perineal Cancer-Related Pain.
title_fullStr Ganglion Impar Neurolysis in the Management of Pelvic and Perineal Cancer-Related Pain.
title_full_unstemmed Ganglion Impar Neurolysis in the Management of Pelvic and Perineal Cancer-Related Pain.
title_sort Ganglion Impar Neurolysis in the Management of Pelvic and Perineal Cancer-Related Pain.
author Ferreira, F
author_facet Ferreira, F
Pedro, A
author_role author
author2 Pedro, A
author2_role author
dc.contributor.none.fl_str_mv Repositório do Hospital Prof. Doutor Fernando Fonseca
dc.contributor.author.fl_str_mv Ferreira, F
Pedro, A
dc.subject.por.fl_str_mv Pelvic pain
Neoplasms
Pain management
Morphine
topic Pelvic pain
Neoplasms
Pain management
Morphine
description Cancer-related pain is a very prevalent problem in all stages, with 10% of patients requiring invasive techniques for adequate pain management. Ganglion impar neurolysis has been used in the treatment of pelvic-perineal pain with efficacy and rare complications, but only a few case or series reports in cancer patients have been published. We report the case of a patient presenting with an ovarian carcinoma (FIGO stage IIIC), who had several disease relapses at the colorectal transition and need for palliative colic prosthesis. She presented later with anorectal pain associated with a rectovaginal fistula, which had an important impact on the activities of her daily life. She was submitted to two ganglion impar neurolyses, which resulted in improved pain control for a total of 5 months, an important improvement in her quality of life, and reduction of opioid consumption. The authors aim to alert to the importance of pain control and to address the fourth step of the WHO analgesic ladder as an option for cancer patients, including palliative patients.
publishDate 2020
dc.date.none.fl_str_mv 2020-07-07T13:29:44Z
2020-01-01T00:00:00Z
2020-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/2461
url http://hdl.handle.net/10400.10/2461
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Case Rep Oncol. 2020 Jan 20;13(1):29-34
1662-6575
10.1159/000505181
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Karger
publisher.none.fl_str_mv Karger
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130400606388224